Andera Partners (BioDiscovery)
European life sciences venture capital firm (formerly Edmond de Rothschild Investment Partners). BioDiscovery fund invests in innovative biotechnology and healthcare companies across Europe.
Location
Paris, France
Founded
2001
AUM
€1B+ (BioDiscovery funds)
Investment Range
€5M - €30M
Focus
biotech-focused
Fund Stages
seed, series-a, series-b, series-c
Investment Thesis
Andera Partners' BioDiscovery funds invest in European life sciences companies developing innovative therapeutics, diagnostics, and medical technologies. They focus on companies with strong scientific foundations and clear paths to clinical and commercial success, supporting entrepreneurs from early stage through growth.
Team
Partners / Managing Directors (Health & Bio Focus)
- Olivier Litzka - Managing Partner, BioDiscovery
- Christophe Pottier - Partner, BioDiscovery
- Raphael Wisniewski - Partner, BioDiscovery
Other Key Team Members
- Bruno Beurrier - CEO, Andera Partners
Focus Areas
- Therapeutics
- Oncology
- Rare Diseases
- Diagnostics
- Medical Devices
- Digital Health
- European Life Sciences
Notable Exits
- Cellectis - IPO (2015, NASDAQ: CLLS)
- DBV Technologies - IPO (2014, NASDAQ: DBVT)
- Cerenis Therapeutics - IPO